TKO GROUP HOLDINGS, INC. (TKO) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.53%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value 4.14×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.53% | Share-based compensation / revenue. Period ending 2026-06-30. $134.30M ÷ $5.30B × 100 ≈ 2.53% |
| Interest coverage · 12 months | 4.14× | Operating income ÷ reported interest expense. $997.63M ÷ $240.94M ≈ 4.14× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 5.30B USD | |
| Stock-based compensation | 134.30M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 997.63M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 240.94M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $5.30B | $134.30M | $997.63M | $240.94M | (m) | 2.53% | 4.14× | Reported |
| 2026-03-31 | (m) | $5.06B | $126.90M | $936.13M | $218.52M | (m) | 2.51% | 4.28× | Reported |
| 2025-12-31 | (m) | $4.74B | $117.59M | $835.01M | $202.72M | (m) | 2.48% | 4.12× | Reported |
| 2025-09-30 | (m) | $4.63B | $105.42M | $832.67M | $196.02M | (m) | 2.28% | 4.25× | Reported |
| 2025-06-30 | (m) | $5.05B | $107.74M | $695.34M | $204.61M | (m) | 2.14% | 3.40× | Reported |
| 2025-03-31 | (m) | $4.93B | $101.56M | $441.89M | $219.38M | (m) | 2.06% | 2.01× | Reported |
| 2024-12-31 | (m) | $2.80B | $94.64M | $282.90M | $249.12M | (m) | 3.37% | 1.14× | Reported |
| 2024-09-30 | (m) | $2.78B | $95.60M | $243.85M | $259.47M | (m) | 3.44% | 0.94× | Reported |
| 2024-06-30 | (m) | $2.54B | $100.12M | $201.32M | $257.46M | (m) | 3.94% | 0.78× | Reported |
| 2024-03-31 | (m) | $2.00B | $81.54M | $90.24M | $249.60M | (m) | 4.08% | 0.36× | Reported |
| 2023-12-31 | (m) | $1.67B | $57.11M | $446.66M | $239.04M | (m) | 3.41% | 1.87× | Reported |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $1.14B | $23.74M | $544.39M | $139.57M | (m) | 2.08% | 3.90× | Reported |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.03B | $63.85M | $391.14M | $102.25M | (m) | 6.19% | 3.83× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.